Back to search
COVID-19-Associated Acute Respiratory Distress Syndrome (ARDS)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which COVID-19-Associated Acute Respiratory Distress Syndrome (ARDS) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which COVID-19-Associated Acute Respiratory Distress Syndrome (ARDS) trials you may qualify forThis is a phase I trial followed by a phase II randomized trial. The purpose of phase I study is the feasibility of treating patients with acute respiratory dis…
The purpose of this clinical trial is to evaluate the safety, tolerability and efficacy of two doses (dose A and dose B) of Standardized Conditioned Medium Obta…
The investigators developed a GMP protocol to isolate Treg cells from thymic tissue (thyTreg). The thyTreg cells are being evaluated in a Phase I/II clinical tr…
Prospective, randomized, double-blind, placebo-controlled clinical trial evaluating the clinical and molecular effects of intravenous N-acetylcysteine (NAC) in…
This study looks at the safety and effectiveness of different drugs in treating COVID-19 in people who have been hospitalized with the infection and who have ac…
This study looks at the safety and effectiveness of Remdesivir in treating COVID-19 in people who have been hospitalized with the infection and who have acute r…